Acer Medical (ROCO:6857) EBIT: NT$-29.67 Mil (TTM As of Dec. 2025)


ROCO:6857 Acer Medical Inc ROCO:6857
52 GF Score
Price NT$92.00
GF Value NT$261.37
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Acer Medical EBIT?

Acer Medical ROCO:6857 -2.13% 52 EBIT is NT$-29.67 Mil as of Dec. 2025. GuruFocus rates ROCO:6857 with a GF Score™ of 52/100 and a GF Value™ of NT$261.37 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Acer Medical's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was NT$-13.07 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-29.67 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Acer Medical's annualized ROC % for the quarter that ended in Dec. 2025 was -348.60%. Acer Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -1,455.27%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Acer Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -2.42%.

Acer Medical  (ROCO:6857) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Acer Medical's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-32.266 * ( 1 - 0% )/( (7.161 + 11.351)/ 2 )
=-32.266/9.256
=-348.60 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=209.496 - 29.398 - ( 182.274 - max(0, 30.049 - 202.986+182.274))
=7.161

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=207.227 - 37.77 - ( 178.651 - max(0, 42.303 - 200.409+178.651))
=11.351

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Acer Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-26.144/( ( (1.668 + max(-11.965, 0)) + (1.925 + max(-18.415, 0)) )/ 2 )
=-26.144/( ( 1.668 + 1.925 )/ 2 )
=-26.144/1.7965
=-1,455.27 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(10.793 + 4.249 + 2.809) - (29.398 + 0 + 0.418)
=-11.965

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11.449 + 5.887 + 3.972) - (37.77 + 0 + 1.953)
=-18.415

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Acer Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-29.673/1224.721
=-2.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acer Medical EBIT Related Terms

Acer Medical EBIT Historical Data

* Premium members only.

The historical data trend for Acer Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acer Medical EBIT Chart

Acer Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -20.45 -55.18 -41.16 -27.36 -29.67

Acer Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.07 -13.68 -13.69 -16.60 -13.07

ROCO:6857 vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, Acer Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acer Medical EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Acer Medical's EV-to-EBIT falls into.


ROCO:6857
52GF Score
Acer Medical Inc ROCO:6857
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acer Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-29.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of NT$-29.67 Mil mean?
Acer Medical (ROCO:6857) has a EBIT of NT$-29.67 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Acer Medical.
Is Acer Medical's EBIT too high?
Acer Medical's current EBIT is NT$-29.67 Mil. Overall, Acer Medical has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's EBIT compare to VEEV and BTSG?
Acer Medical's EBIT of NT$-29.67 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Acer Medical. Acer Medical's current EBIT is NT$-29.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$261.37, compared to a current price of NT$92.00 — trading 64.8% below its estimated fair value. The current EBIT is NT$-29.67 Mil. Acer Medical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current EBIT is NT$-29.67 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acer Medical (ROCO:6857) Overvalued in 2026?

Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued. The current stock price of NT$92.00 is trading 64.8% below its estimated GF Value™ of NT$261.37. GuruFocus considers Acer Medical to be Significantly Undervalued.

Key valuation signals for ROCO:6857:

  • EBIT: NT$-29.67 Mil
  • GF Value™: NT$261.37 vs. price of NT$92.00 (64.8% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acer Medical Business Description

Address Xintai 5th Road, 7th Floor, No. 86, Section 1, Xizhi District, New Taipei, TWN
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
52GF Score

Get the complete analysis for ROCO:6857

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$92.00
Price
NT$261.37
GF Value